SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Directors' Interests

5 Jul 2012 16:16

RNS Number : 0480H
Accsys Technologies PLC
05 July 2012
 



AIM: AXS

NYSE Euronext Amsterdam: AXS

5 July 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Directors' Interests

 

The Company announces that in connection with employee remuneration and incentivisation arrangements and in respect of the period from 1 July 2011 to 30 June 2012, following recommendation from the nomination and remuneration committee of the Company, the Board has resolved to issue Ordinary Shares to an Employee Benefit Trust, the beneficiaries of which include executive Directors.

 

Such Ordinary Shares shall vest if the employees, including the executive Directors, remain in employment with the Company to the vesting date, being 1 July 2013 (subject to certain other provisions including good-leaver, take-over and committee discretion provisions).

 

A total of 3,926,666 Ordinary Shares will be issued to the Employee Benefit Trust, of which 2,166,666 relate to the executive Directors as set out below:

 

Name Number Number of Ordinary Shares

Paul Clegg 1,500,000

Hans Pauli 666,666

 

All Ordinary Shares will be issued pending admission to trading on AIM and Euronext which is expected to take place on 6 July 2012.

 

The issued share capital of the Company following admission will be 407,943,308.

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, and an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc). All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

 

Accoya®, Tricoya®, the Trimarque Device and the Elements logo are registered trademarks owned by Titan Wood Limited and may not be used or reproduced without written permission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASXSEFLAEFF
Date   Source Headline
21st Sep 20164:55 pmRNSAGM Proxy Results
7th Sep 20164:57 pmRNSTotal Voting Rights
30th Aug 20164:35 pmRNSPrice Monitoring Extension
9th Aug 201612:07 pmRNSNotice of AGM
8th Aug 20163:38 pmRNSAccsys Employee Share Participation Plan
20th Jul 20164:37 pmRNSEmployee Benefit Trust and Directors' Interests
28th Jun 20168:42 amRNSDirectors' Interests, Shares to Employees & TVR
15th Jun 20167:00 amRNSPreliminary Results for year ended 31 March 2016
3rd Feb 20167:00 amRNSBP Ventures participates in Tricoya Consortium
1st Feb 201610:17 amRNSTotal Voting Rights
22nd Jan 201612:16 pmRNSEmployee Share Plan
24th Dec 20159:51 amRNSIssue of Equity
4th Dec 20153:59 pmRNSEmployee Benefit Trust
30th Nov 20154:58 pmRNSNotifiable Interest - Henderson Group
30th Nov 20157:00 amRNSInterim results
26th Nov 20157:00 amRNSEnhanced collaboration with Solvay
27th Oct 20154:57 pmRNSNotifiable Interest
17th Sep 20153:17 pmRNSResult of AGM
28th Aug 20152:35 pmRNSTotal Voting Rights
21st Aug 20157:00 amRNSNotice of AGM
15th Jul 20154:27 pmRNSDirector's Interests
2nd Jul 20154:06 pmRNSNotifiable Interest
1st Jul 20154:53 pmRNSEmployee Benefit Trust and Directors' Interests
30th Jun 20154:47 pmRNSDirectors' Interests, Issue of Shares to Employees
16th Jun 20157:00 amRNSPreliminary Results for year ended 31 March 2015
1st Apr 20157:00 amRNSTricoya Technologies Limited Changes
12th Feb 20157:00 amRNSThird Quarter Trading Update
4th Feb 20154:57 pmRNSNotifiable Interest - Majedie UK Equity Fund
2nd Feb 20151:57 pmRNSTotal Voting Rights
22nd Jan 20154:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20154:35 pmRNSPrice Monitoring Extension
13th Jan 20154:23 pmRNSEmployee Share Participation Plan
28th Nov 20147:00 amRNSBoard Appointments
24th Nov 20147:00 amRNSInterim Results
20th Nov 20143:54 pmRNSInterim results release date and webcast
27th Oct 20144:53 pmRNSEmployee Benefit Trust and Directors' Interests
1st Oct 20145:23 pmRNSTotal Voting Rights
30th Sep 20144:56 pmRNSPre Close Trading Update and EBT sale of shares
24th Sep 20142:33 pmRNSDirector Shareholding
19th Sep 201412:00 pmRNSDiamond Wood Licence agreement
11th Sep 20144:08 pmRNSResult of Annual General Meeting
11th Sep 20147:00 amRNSAGM Statement
29th Aug 201410:13 amRNSTotal Voting Rights
19th Aug 20143:52 pmRNSNotice of AGM
13th Aug 20147:00 amRNSInterim Management Statement
12th Aug 20144:00 pmRNSDirectors' Interests and Employee Share Plan
6th Aug 20147:00 amRNSSolvay global co-operation agreement
25th Jul 20147:00 amRNSDiamond Wood Licence Agreement
3rd Jul 20147:00 amRNSPreliminary results for the year ended March 2014
2nd Jul 20144:49 pmRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.